Hans Ehrencrona

Head of Clinical Genetics

Skåne University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Medical Science Medical Science professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hans Ehrencrona is the Head of Clinical Genetics at Skåne University Hospital in Sweden. His research areas include hereditary cancer risk disclosure, genome sequencing in heart failure, and the complexities of chromosomal rearrangements. He is actively involved in initiatives such as the Precision Omics Initiative Sweden (PROMISE) and has contributed significantly to studies on genetic counseling legislation across EU Member States. His recent work highlights the intersection of healthcare and genetic research, focusing on practical applications for cancer treatment and genetic testing.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (9)

Sonja Strang-Karlsson

University of Helsinki

FINLAND

View details

Joel Wallenius

Lund University

SWEDEN

View details

Anna Lindstrand

Professor

Karolinska Institutet

SWEDEN

View details

Ann Nordgren

Professor

University of Gothenburg

SWEDEN

View details

Adam Ameur

Uppsala University

SWEDEN

View details

Maria Landqvist Waldö

Lund University

SWEDEN

View details

Åsa Johansson

Uppsala University

SWEDEN

View details

Tomasz Stokłosa

POLAND

View details

Malin Levin

Professor, Head of department

University of Gothenburg

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hans Ehrencrona

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare.

Whole genome sequencing in early onset advanced heart failure.

Direct letters to relatives at risk of hereditary cancer—a randomised trial on healthcare-assisted versus family-mediated risk disclosure

Genetic counselling legislation and practice in cancer in EU Member States

Exonic trinucleotide repeat expansions in ZFHX3 cause spinocerebellar ataxia type 4

A national long-read sequencing study on chromosomal rearrangements uncovers hidden complexities.

Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.

Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives

Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).

Collaborators (9)

Sonja Strang-Karlsson

Joel Wallenius

Anna Lindstrand

Ann Nordgren

Adam Ameur

Maria Landqvist Waldö

Åsa Johansson

Tomasz Stokłosa

Malin Levin

Make your next move.